Repeated penile girth enhancement with biodegradable scaffolds: microscopic ultrastructural analysis

来源 :亚洲男性学杂志(英文版) | 被引量 : 0次 | 上传用户:cocomalully
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Autologous tissue engineering using biodegradable scaffolds as a carrier is a well-known procedure for penile girth enhancement. We evaluated a group of previously treated patients with the aim to analyze histomorphometric changes after tissue remodeling and to estimate the benefits of repeated procedure. Between February 2012 and December 2016,a group of 21 patients, aged 22-37 (mean 28.0) years, underwent a repeated penile girth enhancement procedure with biodegradable scaffolds. Procedure included insertion of two poly-lactic-co-glycolic acid scaffolds seeded with laboratory-prepared fibroblasts from scrotal tissue specimens. During this procedure, biopsy specimens of tissue formed after the first surgery were taken for microscopic analysis. The mean follow-up was 38 months. Connective tissue with an abundance of connective tissue fibers, small blood vessels, and inflammatory cells were observed in all analyzed surgically removed tissue. Ultrastructural analysis of these tissue samples discovered the presence of large quantities of collagen fibrils running parallel to each other, forming bundles, with a few widely spread fibroblasts. In total, the mean values of flaccid and erect gain in girth after the second surgery were 1.1 ± 0.4 (range: 0.6-1.7) cm and 1.0 ± 0.3 (range: 0.6-1.5) cm, respectively. Microscopic evaluation of newly formed tissue, induced by autologous tissue engineering using biodegradable scaffolds, showed the presence of vascularized loose connective tissue with an abundance of collagen fibers, fibroblasts, and inflammatory cells, indicating active neovascularization and fibrinogenesis. The benefit of the repeated enhancement procedure was statistically significant.
其他文献
Aim: To investigate human epidermal growth factor receptor type 2 (HER2) protein expression and gene amplification in Chinese metastatic prostate cancer patients and their potential value as prognostic factors. Methods: Immuno-histochemistry (IHC) was per
Prostate cancer is among the most common malignancies in Western countries,and its incidence is rapidly rising in Asia where it was traditionally considered an uncommon tumor.Our understanding of the disease and management strategies continue to evolve.Th
期刊
The prognostic significance of initial prostate-specific antigen (PSA) level for metastatic prostate cancer remains uncertain. We investigated the differences in prognosis and response to hormonal therapies of metastatic prostate cancer patients according
Dear Editor,rnCongenital bilateral absence of the vas deferens (CBAVD),a complete or partial defect of the Wolffian duct derivatives,is found in >25% of men with obstructive azoospermia (OA),but the underlying pathological mechanism remains poorly underst
期刊
Dear Editor,rnIntrauterine insemination (IUI) is mainly indicated in cases of unexplained or mild male subfertility. In these cases, gonadotropin ovarian stimulation combined with gonadotropin-releasing hormone (GnRH) antagonist IUI leads to up to an 18%
期刊
Late-onset hypogonadism (LOH) has been described as a clinical syndrome comprising symptoms consistent with androgen deficiency and a circulating concentration of testosterone in the low-to-normal range insome middle-aged and elderly men.
期刊
The current literature does not support the usefulness of clinical markers on predicting which patients with atypical small acinar proliferation (ASAP) are more likely to progress to prostate cancer (PCa). Androgens have long been considered to be the pot
Urge urinary incontinence (UUl) is one of the most troublesome complications of surgery of the prostate whether for malignancy or benign conditions.For many decades,there have been attempts to reduce the morbidity of this outcome with variable results.Sin